(Q36833022)

16 August 2017

1 reference

title

From Mallory to Mallory-Denk bodies: what, how and why? (English)

1 reference

16 August 2017

1

Kurt Zatloukal

1 reference

16 August 2017

4

Pavel Strnad

1 reference

16 August 2017

Samuel W French

2

1 reference

16 August 2017

Cornelia Stumptner

3

1 reference

16 August 2017

Masaru Harada

5

1 reference

16 August 2017

Diana M Toivola

6

1 reference

16 August 2017

Monique Cadrin

7

1 reference

16 August 2017

M Bishr Omary

8

1 reference

16 August 2017

language of work or name

English

0 references

publication date

27 April 2007

1 reference

Experimental Cell Research

16 August 2017

published in

1 reference

16 August 2017

volume

313

1 reference

16 August 2017

issue

10

1 reference

16 August 2017

page(s)

2033-2049

1 reference

16 August 2017

cites work

Mallory bodies revisited

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

The mallory body: Morphological, clinical and experimental studies (part 1 of a literature survey)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

The mallory body: Theories on development and pathological significance (part 2 of a literature survey)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Formation and involution of Mallory bodies ("alcoholic hyalin") in murine and human liver revealed by immunofluorescence microscopy with antibodies to prekeratin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Cytokeratin 8 protects from hepatotoxicity, and its ratio to cytokeratin 18 determines the ability of hepatocytes to form Mallory bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Are the Mallory bodies and intracellular hyaline bodies in neoplastic and non-neoplastic hepatocytes related?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

'Hard' and 'soft' principles defining the structure, function and regulation of keratin intermediate filaments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Intermediate filament proteins and their associated diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Congenital myopathies at their molecular dawning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Alexander disease-associated glial fibrillary acidic protein mutations in mice induce Rosenthal fiber formation and a white matter stress response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

The cytoskeleton in neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Immunohistochemical profiles of Mallory body by a panel of anti-cytokeratin antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

De novo expression of nonhepatocellular cytokeratins in Mallory body formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

"Heads and tails" of intermediate filament phosphorylation: multiple sites and functional insights.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Posttranslational events involved in griseofulvin-induced keratin cytoskeleton alterations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Heat shock protein 70 expression, keratin phosphorylation and Mallory body formation in hepatocytes from griseofulvin-intoxicated mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Hepatocyte cytokeratins are hyperphosphorylated at multiple sites in human alcoholic hepatitis and in a mallory body mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Cytokeratin of apparent high molecular weight in livers from griseofulvin-fed mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Transglutaminase 2 regulates mallory body inclusion formation and injury-associated liver enlargement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Heat shock proteins are present in mallory bodies (cytokeratin aggresomes) in human liver biopsy specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Interaction of stress proteins with misfolded keratins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

p62 is involved in the mechanism of Mallory body formation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

NEDD8 protein is involved in ubiquitinated inclusion bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

RNA interference of VCP/p97 increases Mallory body formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Fate of Mallory body-containing hepatocytes: Disappearance of Mallory bodies and restoration of the hepatocytic intermediate filament cytoskeleton after drug withdrawal in the griseofulvin-treated mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Alteration in molecular structure of cytoskeleton proteins in griseofulvin-treated mouse liver: a pressure tuning infrared spectroscopy study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Immunohistochemical analysis of Mallory bodies in Wilsonian and non-Wilsonian hepatic copper toxicosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Ground-glass, polyglucosan-like hepatocellular inclusions: A "new" diagnostic entity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Further observations on cytoplasmic hyaline in the lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Immunohistochemical detection of ubiquitin-positive intracytoplasmic eosinophilic inclusion bodies in diffuse alveolar damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Globular Mallory-like bodies in renal cell carcinoma: report of a case and review of cytoplasmic eosinophilic globules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Filamentous inclusions in nonneoplastic and neoplastic pancreas: an ultrastructural and immunogold labeling study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Experimental alcoholic hepatitis: a new primate model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Dieldrin-Induced Mallory Bodies in Hepatic Tumors of Mice of Different Strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Mallory body induction in drug-primed mouse liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Sequence of events in the assembly of Mallory body components in mouse liver: clues to the pathogenesis and significance of Mallory body formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Mallory body--a disease-associated type of sequestosome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Mallory body formation runs parallel to gamma-glutamyl transferase induction in hepatocytes of griseofulvin-fed mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Bile acid-induced Mallory body formation in drug-primed mouse liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Heat shock in vivo induces Mallory body formation in drug primed mouse liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Aggresome formation in liver cells in response to different toxic mechanisms: role of the ubiquitin-proteasome pathway and the frameshift mutant of ubiquitin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Mechanisms of mallory body formation induced by okadaic acid in drug-primed mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Preneoplastic liver cell foci expansion induced by thioacetamide toxicity in drug-primed mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Mallory body formation by ethanol feeding in drug-primed mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Keratin 8 overexpression promotes mouse Mallory body formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Lessons from keratin 18 knockout mice: formation of novel keratin filaments, secondary loss of keratin 7 and accumulation of liver-specific keratin 8-positive aggregates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Keratin 18 overexpression but not phosphorylation or filament organization blocks mouse Mallory body formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Chronic hepatitis, hepatocyte fragility, and increased soluble phosphoglycokeratins in transgenic mice expressing a keratin 18 conserved arginine mutant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Transglutaminases: crosslinking enzymes with pleiotropic functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

The proteasome inhibitor, PS-341, causes cytokeratin aggresome formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Mallory body (cytokeratin aggresomes) formation is prevented in vitro by p38 inhibitor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Expression of a mutant ER-retained polytope membrane protein in cultured rat hepatocytes results in Mallory body formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Formation of Mallory body-like inclusions and cell death induced by deregulated expression of keratin 18.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Proteasome inhibition induces inclusion bodies associated with intermediate filaments and fragmentation of the Golgi apparatus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Keratin-containing inclusions affect cell morphology and distribution of cytosolic cellular components.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Uncovering the roles of intermediate filaments in apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

The role of laminin-integrin signaling in triggering MB formation. An in vivo and in vitro study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Protein degradation and protection against misfolded or damaged proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Sick chaperones, cellular stress, and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Modification of heat shock protein 90 by 4-hydroxynonenal in a rat model of chronic alcoholic liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Protein quality control: chaperones culling corrupt conformations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

p62, a phosphotyrosine-independent ligand of the SH2 domain of p56lck, belongs to a new class of ubiquitin-binding proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

The atypical PKC-interacting protein p62 channels NF-kappaB activation by the IL-1-TRAF6 pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Organ-specific stress induces mouse pancreatic keratin overexpression in association with NF-kappaB activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

The p105/50 NF-kappaB pathway is essential for Mallory body formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Molecular mechanisms of amyloidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Protein aggregation and neurodegenerative disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Keratin 8 phosphorylation by p38 kinase regulates cellular keratin filament reorganization: modulation by a keratin 1-like disease causing mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

A disease- and phosphorylation-related nonmechanical function for keratin 8.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Keratins turn over by ubiquitination in a phosphorylation-modulated fashion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Low levels of asparagine deamidation can have a dramatic effect on aggregation of amyloidogenic peptides: implications for the study of amyloid formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Transglutaminase potentiates ligand-dependent proteasome dysfunction induced by polyglutamine-expanded androgen receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

The role of the ubiquitin-proteasome pathway in the formation of mallory bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Mallory bodies formed in proteasome-depleted hepatocytes: an immunohistochemical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Proteasomes and their kin: proteases in the machine age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Effects of chronic ethanol administration on rat liver proteasome activities: relationship with oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Molecular misreading of the ubiquitin B gene and hepatic mallory body formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Alcoholic liver disease: pathologic, pathogenetic and clinical aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Pathology of alcoholic liver disease. VA Cooperative Study Group 119.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Nonalcoholic steatohepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Histological assessment of non-alcoholic fatty liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Distribution patterns of cytokeratin antigen determinants in alcoholic and nonalcoholic liver diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Proposal for a histological scoring and grading system for non-alcoholic fatty liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Pathologic features associated with fibrosis in nonalcoholic fatty liver disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Impairment of the ubiquitin-proteasome system by protein aggregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Alcoholic hepatitis: Granulocyte chemotactic factor from Mallory body-stimulated human peripheral blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Enzyme-histochemical studies of griseofulvin-intoxicated mouse livers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Intermediate filament protein inclusions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Keratin 8 and 18 hyperphosphorylation is a marker of progression of human liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodie

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

Analysis of intracytoplasmic hyaline bodies in a hepatocellular carcinoma. Demonstration of p62 as major constituent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

The Mallory body as an aggresome: in vitro studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.024

10.1016/J.YEXCR.2007.04.024

7 January 2021

Identifiers

DOI

1 reference

16 August 2017

1 reference